دورية أكاديمية

Impact of exercise training on preeclampsia: potential preventive mechanisms.

التفاصيل البيبلوغرافية
العنوان: Impact of exercise training on preeclampsia: potential preventive mechanisms.
المؤلفون: Genest DS, Falcao S, Gutkowska J, Lavoie JL, Genest, Dominique S, Falcao, Stéphanie, Gutkowska, Jolanta, Lavoie, Julie L
المصدر: Hypertension (0194911X); Nov2012, Vol. 60 Issue 5, p1104-1109, 6p
مستخلص: Preeclampsia is characterized by hypertension and de novo proteinuria after 20 weeks of pregnancy. It is the leading cause of perinatal morbidity and mortality in the developed world, and to date, the only means of treating the disease is by inducing delivery. Many studies have shown the benefits of exercise training on normal pregnancy. Conversely, because the impact of exercise on reducing the risk of preeclampsia has long been debated, the American College of Obstetricians and Gynecologists has yet to support the prescription of exercise training to women at risk of developing the disease. There is, however, a significant body of evidence in support of the protective role of exercise training against preeclampsia. A recent animal study demonstrated that many preeclampsia features can be eliminated with prenatal followed by gestational exercise training. Hence, the present article reviews the literature on the impact of exercise training on preeclampsia risk, as well as the mechanisms that may be involved. [ABSTRACT FROM AUTHOR]
Copyright of Hypertension (0194911X) is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0194911X
DOI:10.1161/HYPERTENSIONAHA.112.194050